Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
JEC Democrats scrutinize Trump's soaring pharma holdings
Key to the report are findings that Donald Trump increased his pharmaceutical stock holdings to as much as $56.2 million by the end of 2025.
Fraiser Kansteiner
Oct 16, 2026 2:50pm
The Oral GLP-1 Tracker: Lilly, Novo undergo minor fluctuations
Oct 16, 2026 2:25pm
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Lilly, RevMed win key recommendations from European regulators
Oct 16, 2026 11:30am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Fierce Biotech
China looks to ban foreign acquisitions of key biotech platforms
Oct 16, 2026 10:38am
